This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tugrul, K. C. Search for Related Content Social Bookmarking                         What's this?

Pharmacologic Treatment of Schizophrenia: A Review

Biological Psychiatry Program, P. O. Box 670550, 231 Bethesda Ave., Cincinnati, OH 45267-0559.

Standard antipsychotic agents, such as haloperidol and chlorpromazine, continue to be the mainstay of pharmacologic treatment for schizophrenia. However, standard antipsychotics, although effective for the positive symptoms of schizophrenia, have little or no effect on the negative symptoms of this disease. Standard antipsychotics also are associated with the development of potentially disabling side effects, such as extrapyramidal symptoms and tardive dyskinesia. Newer agents, such as clozapine and risperidone, are effective for both positive and negative symptoms. They also are less likely to cause extrapyramidal symptoms.

Journal of the American Psychiatric Nurses Association, Vol. 1, No. 6, 208-213 (1995)
DOI: 10.1177/107839039500100612


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?